Deissler H - Search Results

1

Efficient gene transfer of CD40 ligand into ovarian carcinoma cells with a recombinant adeno-associated virus vector.

Koppold B, Sauer G, Büning H, Hallek M, Kreienberg R, Deissler H, Kurzeder C. Koppold B, et al. Among authors: deissler h. Int J Oncol. 2005 Jan;26(1):95-101. Int J Oncol. 2005. PMID: 15586229

2

Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells.

Sauer G, Kurzeder C, Grundmann R, Kreienberg R, Zeillinger R, Deissler H. Sauer G, et al. Among authors: deissler h. Oncol Rep. 2003 Mar-Apr;10(2):405-10. Oncol Rep. 2003. PMID: 12579280

3

Chemotherapeutic agents enhance AAV2-mediated gene transfer into breast cancer cells promoting CD40 ligand-based immunotherapy.

Koppold B, Sauer G, Buening H, Hallek M, Kreienberg R, Deissler H, Kurzeder C. Koppold B, et al. Among authors: deissler h. J Cancer Res Clin Oncol. 2006 Dec;132(12):787-94. doi: 10.1007/s00432-006-0127-3. Epub 2006 Jun 23. J Cancer Res Clin Oncol. 2006. PMID: 16794829

4

CD9 promotes adeno-associated virus type 2 infection of mammary carcinoma cells with low cell surface expression of heparan sulphate proteoglycans.

Kurzeder C, Koppold B, Sauer G, Pabst S, Kreienberg R, Deissler H. Kurzeder C, et al. Among authors: deissler h. Int J Mol Med. 2007 Feb;19(2):325-33. Int J Mol Med. 2007. PMID: 17203208

5

New molecular targets of breast cancer therapy.

Sauer G, Deissler H, Kurzeder C, Kreienberg R. Sauer G, et al. Among authors: deissler h. Strahlenther Onkol. 2002 Mar;178(3):123-33. doi: 10.1007/s00066-002-0957-0. Strahlenther Onkol. 2002. PMID: 11962188 Review.

6

Basal expression of the multidrug resistance gene 1 (MDR-1) is associated with the TT genotype at the polymorphic site C3435T in mammary and ovarian carcinoma cell lines.

Sauer G, Kafka A, Grundmann R, Kreienberg R, Zeillinger R, Deissler H. Sauer G, et al. Among authors: deissler h. Cancer Lett. 2002 Nov 8;185(1):79-85. doi: 10.1016/s0304-3835(02)00232-x. Cancer Lett. 2002. PMID: 12142082

7

Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer.

Kafka A, Sauer G, Jaeger C, Grundmann R, Kreienberg R, Zeillinger R, Deissler H. Kafka A, et al. Among authors: deissler h. Int J Oncol. 2003 May;22(5):1117-21. Int J Oncol. 2003. PMID: 12684679

8

Spectrum of p53 mutations in biopsies from breast cancer patients selected for preoperative chemotherapy analysed by the functional yeast assay to predict therapeutic response.

Deissler H, Kafka A, Schuster E, Sauer G, Kreienberg R, Zeillinger R. Deissler H, et al. Oncol Rep. 2004 Jun;11(6):1281-6. Oncol Rep. 2004. PMID: 15138567

9

Immunotherapy and cancer vaccines in the management of breast cancer.

Sauer G, Kurzeder C, Heilmann V, Kreienberg R, Deissler H. Sauer G, et al. Among authors: deissler h. Curr Pharm Des. 2005;11(27):3475-83. doi: 10.2174/138161205774414547. Curr Pharm Des. 2005. PMID: 16248802 Review.

10

Molecular targets of ovarian carcinomas with acquired resistance to platinum/taxane chemotherapy.

Kurzeder C, Sauer G, Deissler H. Kurzeder C, et al. Among authors: deissler h. Curr Cancer Drug Targets. 2006 May;6(3):207-27. doi: 10.2174/156800906776842975. Curr Cancer Drug Targets. 2006. PMID: 16712458 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters